Cite
Chaparro M, Barreiro-de Acosta M, Benítez JM, et al. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. Therap Adv Gastroenterol. 2019;12:1756284819847034doi: 10.1177/1756284819847034.
Chaparro, M., Barreiro-de Acosta, M., Benítez, J. M., Cabriada, J. L., Casanova, M. J., Ceballos, D., Esteve, M., Fernández, H., Ginard, D., Gomollón, F., Lorente, R., Nos, P., Riestra, S., Rivero, M., Robledo, P., Rodríguez, C., Sicilia, B., Torrella, E., Garre, A., García-Esquinas, E., Rodríguez-Artalejo, F., Gisbert, J. P. (2019). EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. Therapeutic advances in gastroenterology, 121756284819847034. https://doi.org/10.1177/1756284819847034
Chaparro, María, et al. "EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain." Therapeutic advances in gastroenterology vol. 12 (2019): 1756284819847034. doi: https://doi.org/10.1177/1756284819847034
Chaparro M, Barreiro-de Acosta M, Benítez JM, Cabriada JL, Casanova MJ, Ceballos D, Esteve M, Fernández H, Ginard D, Gomollón F, Lorente R, Nos P, Riestra S, Rivero M, Robledo P, Rodríguez C, Sicilia B, Torrella E, Garre A, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. Therap Adv Gastroenterol. 2019 May 21;12:1756284819847034. doi: 10.1177/1756284819847034. eCollection 2019. PMID: 31205485; PMCID: PMC6535735.
Copy
Download .nbib